Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Guidelines
| Authors: | Loibl, S.; AndreĢ, F.; Bachelot, T.; Barrios, C. H.; Bergh, J.; Burstein, H. J.; Cardoso, M. J.; Carey, L. A.; Dawood, S.; Del Mastro, L.; Denkert, C.; Fallenberg, E. M.; Francis, P. A.; Gamal-Eldin, H.; Gelmon, K.; Geyer, C. E.; Gnant, M.; Guarneri, V.; Gupta, S.; Kim, S. B.; Krug, D.; Martin, M.; Meattini, I.; Morrow, M.; Janni, W.; Paluch-Shimon, S.; Partridge, A.; Poortmans, P.; Pusztai, L.; Regan, M. M.; Sparano, J.; Spanic, T.; Swain, S.; Tjulandin, S.; Toi, M.; Trapani, D.; Tutt, A.; Xu, B.; Curigliano, G.; Harbeck, N.; on behalf of the ESMO Guidelines Committee |
| Title: | Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up |
| Keywords: | histopathology; cancer risk; side effect; systemic therapy; neoadjuvant therapy; treatment; cancer staging; follow up; cancer diagnosis; biological marker; breast cancer; mastectomy; incidence; cancer screening; practice guideline; breast reconstruction; risk assessment; protein tyrosine kinase inhibitor; minimal residual disease; early cancer; screening; diagnosis; survivorship; interpersonal communication; molecular biology; drug therapy; adverse drug reaction; follow-up; pathological complete response; shared decision making; guideline; early breast cancer; human epidermal growth factor receptor 2 positive breast cancer; human; article |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | 2 |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-02-01 |
| Start Page: | 159 |
| End Page: | 182 |
| Language: | English |
| DOI: | 10.1016/j.annonc.2023.11.016 |
| PUBMED: | 38101773 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
